The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: Autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D)

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Lai, Jin Ping ^a   Liu, Yen Chun ^a   Alimchandani, Meghna ^a   Liu, Qingyan ^a   Aung, Phyu Phyu ^a   Matsuda, Kant ^a   Lee, Chyi Chia R ^a   Tsokos, Maria ^a   Hewitt, Stephen ^a   Rushing, Elisabeth J ^b   Tamura, Deborah ^a   Levens, David L ^a   DiGiovanna, John J ^a   Fine, Howard A ^a   Patronas, Nicholas ^c   Khan, Sikandar G ^a   Kleiner, David E ^a   Oberholtzer, J Carl ^a   Quezado, Martha M ^a   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cachexia; DNA damage; DNA repair; Glioblastoma; Neurodegeneration

Indexed keywords

EID: 85005847209     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-4     Document Type: Article

References (60)

1. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki S, Emmert S, Pike KM, Raziuddin A, Plona TM, DiGiovanna JJ, Tucker MA, Kraemer KH: Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 2011, 48: 168-176. 10.1136/jmg.2010.083022
2. Kraemer KH, Lee MM, Andrews AD, Lambert WC: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994, 130: 1018-1021. 10.1001/archderm.1994.01690080084012
3. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987, 123: 241-250. 10.1001/archderm.1987.01660260111026
4. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG: Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974, 80: 221-248. 10.7326/0003-4819-80-2-221
5. Anttinen A, Koulu L, Nikoskelainen E, Portin R, Kurki T, Erkinjuntti M, Jaspers NG, Raams A, Green MH, Lehmann AR, Wing JF, Arlett CF, Marttila RJ: Neurological symptoms and natural course of xeroderma pigmentosum. Brain 2008, 131: 1979-1989. 10.1093/brain/awn126
6. Itoh M, Hayashi M, Shioda K, Minagawa M, Isa F, Tamagawa K, Morimatsu Y, Oda M: Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev 1999, 21: 326-333. 10.1016/S0387-7604(99)00033-9
7. Kanda T, Oda M, Yonezawa M, Tamagawa K, Isa F, Hanakago R, Tsukagoshi H: Peripheral neuropathy in xeroderma pigmentosum. Brain 1990, 113: 1025-1044. 10.1093/brain/113.4.1025
8. Robbins JH: Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988, 260: 384-388. 10.1001/jama.1988.03410030100038
9. Robbins JH, Brumback RA, Mendiones M, Barrett SF, Carl JR, Cho S, Denckla MB, Ganges MB, Gerber LH, Guthrie RA: Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain 1991, 114: 1335-1361.
10. Robbins JH, Kraemer KH, Merchant SN, Brumback RA: Adult-onset xeroderma pigmentosum neurological disease-observations in an autopsy case. Clin Neuropathol 2002, 21: 18-23.
11. Ueda T, Kanda F, Aoyama N, Fujii M, Nishigori C, Toda T: Neuroimaging features of xeroderma pigmentosum group A. Brain Behav 2012, 2: 1-5.
12. DiGiovanna JJ, Kraemer KH: Shining a light on xeroderma pigmentosum. J Invest Dermatol 2012, 132: 785-796. 10.1038/jid.2011.426
13. Hoeijmakers JH: DNA damage, aging, and cancer. N Engl J Med 2009, 361: 1475-1485. 10.1056/NEJMra0804615
14. Totonchy MB, Tamura D, Pantell MS, Zalewski C, Bradford PT, Merchant SN, Nadol J, Khan SG, Schiffmann R, Pierson TM, Wiggs E, Griffith AJ, DiGiovanna JJ, Kraemer KH, Brewer CC: Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration. Brain 2013, 136: 194-208.
15. de Sanctis C, Cacchione A: L'idiozia xerodermica. Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali 1932, 56: 269-292.
16. Hayashi M: Roles of oxidative stress in xeroderma pigmentosum. Adv Exp Med Biol 2008, 637: 120-127.
17. Hayashi M: Oxidative stress in developmental brain disorders. Neuropathology 2009, 29: 1-8. 10.1111/j.1440-1789.2008.00888.x
18. Hayashi M, Araki S, Kohyama J, Shioda K, Fukatsu R: Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev 2005, 27: 34-38. 10.1016/j.braindev.2004.04.001
19. Hayashi M, Araki S, Kohyama J, Shioda K, Fukatsu R, Tamagawa K: Brainstem and basal ganglia lesions in xeroderma pigmentosum group A. J Neuropathol Exp Neurol 2004, 63: 1048-1057.
20. Hayashi M, Itoh M, Araki S, Kumada S, Shioda K, Tamagawa K, Mizutani T, Morimatsu Y, Minagawa M, Oda M: Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol 2001, 60: 350-356.
21. Hayashi M, Miwa-Saito N: Tanuma N. Neuropathology: Kubota M Brain vascular changes in Cockayne syndrome; 2011.
22. Hayashi M, Ohto T: Shioda K. Brain Dev: Fukatsu R Lesions of cortical GABAergic interneurons and acetylcholine neurons in xeroderma pigmentosum group A; 2011.
23. Kenyon GS, Booth JB, Prasher DK: Rudge P Neuro-otological abnormalities in xeroderma pigmentosum with particular reference to deafness. Brain 1985,108(Pt 3):771-784.
24. Kohji T, Hayashi M, Shioda K, Minagawa M, Morimatsu Y, Tamagawa K, Oda M: Cerebellar neurodegeneration in human hereditary DNA repair disorders. Neurosci Lett 1998, 243: 133-136. 10.1016/S0304-3940(98)00109-8
25. Okayasu I, Satoh Y, Irimajiri T, Mitoh Y: Fetal case of xeroderma pigmentosum-first report of an autopsy case. Acta Pathol Jpn 1978, 28: 459-464.
26. Ramkumar HL, Brooks BP, Cao X, Tamura D, DiGiovanna JJ, Kraemer KH, Chan CC: Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature. Surv Ophthalmol 2011, 56: 348-361. 10.1016/j.survophthal.2011.03.001
27. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH: Cockayne syndrome and xeroderma pigmentosum. Neurology 2000, 55: 1442-1449. 10.1212/WNL.55.10.1442
28. Reed WB, Landing B, Sugarman G, Cleaver JE, Melnyk J: Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect. JAMA 1969, 207: 2073-2079.
29. Reed WB, MARY SB, NICKEL WR: Xeroderma pigmentosum with neurological complications: The deSanctis-Cacchione syndrome. Arch Dermatol 1965, 91: 224-226. 10.1001/archderm.1965.01600090032005
30. Reed WB, Sugarman GI, Mathis RA: DeSanctis-Cacchione syndrome. A case report with autopsy findings. Arch Dermatol 1977, 113: 1561-1563. 10.1001/archderm.1977.01640110081013
31. Roytta M, Anttinen A: Xeroderma pigmentosum with neurological abnormalities. A clinical and neuropathological study. Acta Neurol Scand 1986, 73: 191-199. 10.1111/j.1600-0447.1986.tb10586.x
32. Takagi M: Xeroderma pigmentosum-report of two autopsy cases (author's transl). Kokubyo Gakkai Zasshi 1979, 46: 389-396.
33. Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH: Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. J Invest Dermatol 2010, 130: 1188-1191. 10.1038/jid.2009.377
34. Yano K: Xeroderma pigmentosum with disorders of the central nervous system; a histopathological study. Folia Psychiatr Neurol Jpn 1950, 4: 143-175.
35. Kraemer KH, Coon HG, Petinga RA, Barrett SF, Rahe AE, Robbins JH: Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc Natl Acad Sci U S A 1975, 72: 59-63. 10.1073/pnas.72.1.59
36. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL: Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988, 318: 1633-1637. 10.1056/NEJM198806233182501
37. States JC, Myrand SP: Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease. Mutat Res 1996, 363: 171-177. 10.1016/0921-8777(96)00004-3
38. Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC: Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes. Gene Ther 2004, 11: 1729-1734. 10.1038/sj.gt.3302344
39. Kraemer KH, De Weerd-Kastelein EA, Robbins JH, Keijzer W, Barrett SF, Petinga RA, Bootsma D: Five complementation groups in xeroderma pigmentosum. Mutat Res 1975, 33: 327-340. 10.1016/0027-5107(75)90208-0
40. Petinga RA, Andrews AD, Tarone RE, Robbins JH: Typical xeroderma pigmentosum complementation group A fibroblasts have detectable ultraviolet light-induced unscheduled DNA synthesis. Biochim Biophys Acta 1977, 479: 400-410. 10.1016/0005-2787(77)90033-8
41. Andrews AD, Barrett SF, Robbins JH: Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc Natl Acad Sci U S A 1978, 75: 1984-1988. 10.1073/pnas.75.4.1984
42. DiGiovanna JJ, Patronas N, Katz D, Abangan D, Kraemer KH: Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg 1998, 2: 153-158.
43. Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, DiGiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH: Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006, 27: 84-94.
44. Robbins JH, Brumback RA, Moshell AN: Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur Neurol 1993, 33: 188-190. 10.1159/000116932
45. Robbins JH, Polinsky RJ, Moshell AN: Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum. Ann Neurol 1983, 13: 682-684. 10.1002/ana.410130621
46. Stern JB, Peck GL, Haupt HM, Hollingsworth HC, Beckerman T: Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion. J Am Acad Dermatol 1993, 28: 591-594. 10.1016/0190-9622(93)70079-9
47. Turner ML, Moshell AN, Corbett DW, Stern JB, Roth MJ, DiGiovanna J, Horn TD, Kraemer KH: Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum. Arch Dermatol 1994, 130: 1491-1494. 10.1001/archderm.1994.01690120027003
48. Gaasterland DE, Rodrigues MM, Moshell AN: Ocular involvement in xeroderma pigmentosum. Ophthalmology 1982, 89: 980-986.
49. Li L, Bales ES, Peterson CA, Legerski RJ: Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 1993, 5: 413-417. 10.1038/ng1293-413
50. Dobbing J, Sands J: Quantitative growth and development of human brain. Arch Dis Child 1973, 48: 757-767. 10.1136/adc.48.10.757
51. Fukuhara N, Kumamoto T, Takasawa H, Tsubaki T, Origuchi Y: The peripheral neuropathy in De Sanctis-Cacchione syndrome. Histological, ultrastructural, and morphometric studies. Acta Neuropathol (Berl) 1982, 56: 194-200. 10.1007/BF00690635
52. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD: IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009, 360: 765-773. 10.1056/NEJMoa0808710
53. Robbins JH, Moshell AN: DNA repair processes protect human beings from premature solar skin damage: evidence from studies on xeroderma pigmentosum. J Invest Dermatol 1979, 73: 102-107. 10.1111/1523-1747.ep12532789
54. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ: Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: A complex genotype-phenotype relationship. Neuroscience 2007, 145: 1388-1396. 10.1016/j.neuroscience.2006.12.020
55. Jaarsma D, Van DP I, De Waard MC, Haasdijk ED, Brandt R, Vermeij M, Rijksen Y, Maas A, Van SH, Hoeijmakers JH: Van der Horst GT Age-related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology. PLoS Genet 2011, 7: 1002405. 10.1371/journal.pgen.1002405
56. Faghri S, Tamura D, Kraemer KH, DiGiovanna JJ: Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 2008, 45: 609-621. 10.1136/jmg.2008.058743
57. Daya-Grosjean L, Sarasin A: The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 2005, 571: 43-56. 10.1016/j.mrfmmm.2004.11.013
58. Wang Y, DiGiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH: Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A 2009, 106: 6279-6284. 10.1073/pnas.0812401106
59. Brooks PJ: The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 2007, 145: 1407-1417. 10.1016/j.neuroscience.2006.10.025
60. de Waard MC, van der Pluijm I, Zuiderveen BN, Comley LH, Haasdijk ED, Rijksen Y, Ridwan Y, Zondag G, Hoeijmakers JH, Elgersma Y, Gillingwater TH, Jaarsma D: Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol 2010, 120: 461-475. 10.1007/s00401-010-0715-9